Adverum Biotechnologies, Inc. (ADVM) Social Stream
ADVERUM BIOTECHNOLOGIES INC (ADVM) Price Targets From Analysts
Use the tables below to see what analysts covering ADVERUM BIOTECHNOLOGIES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 6 | $6 | $3 | $4.25 | $0.8 | 431.25% |
| 2022-03-30 | 4 | $6 | $4 | $5 | $0.8 | 525% |
| 2022-04-11 | 4 | $4 | $3 | $3.5 | $0.8 | 337.5% |
| 2022-05-15 | 3 | $4 | $3 | $3.5 | $0.8 | 337.5% |
| 2022-05-27 | 3 | $3 | $3 | $3 | $0.8 | 275% |
| 2022-07-07 | 3 | $4 | $3 | $3.5 | $0.8 | 337.5% |
| 2022-08-15 | 3 | $4 | $2.5 | $3.25 | $0.8 | 306.25% |
| 2022-08-16 | 3 | $6 | $2.5 | $4.25 | $0.8 | 431.25% |
| 2022-11-14 | 4 | $6 | $2 | $3.666 | $0.8 | 358.25% |
| 2023-03-07 | 4 | $6 | $2 | $3.25 | $0.8 | 306.25% |
The Trend in the Analyst Price Target
ADVM's average price target has moved down $0.32 over the prior 18 months.
Over the past 49 weeks, ADVM's average upside potential has been 256.38%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-30 | 3 | 6 | 4.0 | 5.00 | 1.34 | 273.13% |
| 2022-04-11 | 4 | 4 | 3.0 | 3.50 | 1.17 | 199.15% |
| 2022-07-07 | 3 | 4 | 3.0 | 3.50 | 1.40 | 150% |
| 2022-08-12 | 3 | 4 | 2.5 | 3.25 | 1.47 | 121.09% |
| 2022-08-16 | 3 | 6 | 2.5 | 4.25 | 1.40 | 203.57% |
ADVM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
ADVM's average broker recommendation rating worsened by 0.56 over the prior 28 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ADVM has a higher average analyst price target than 37.5% of all US stocks.
- In terms of how ADVERUM BIOTECHNOLOGIES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1262.81% of that group.
- ADVM has a greater number of analysts covering the stock than 265.61% of Healthcare stocks.
- In terms of how ADVERUM BIOTECHNOLOGIES INC fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -637.64% of that group.
In the Pharmaceutical Products industry, CHRS, ATRA, and CGEN are the three stocks most similar to ADVERUM BIOTECHNOLOGIES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for ADVM? Use POWR Ratings for clearer insight into price direction.